Vectorious Medical Technologies Ltd

Vectorious Medical Technologies develops the V-LAP platform, an investigational implantable sensor for real-time heart-failure management. Implanted in the heart’s interatrial septum, it measures left atrial pressure and transmits daily data to support physician-guided, patient self-management of chronic heart failure. The company aims to develop scalable therapies based on implantable sensing platforms that provide reliable, actionable clinical information and help reduce disease deterioration and hospitalizations.